Literature DB >> 7249915

Verification of the biphasic response in intraocular pressure during treatment of glaucoma patients with 3% guanethidine and 0.5% adrenaline.

P F Hoyng.   

Abstract

In a long-term study with 3% guanethidine and 0.5% adrenaline in on eye drop (GA) the combined results of patients with primary open angle glaucoma (POAG) and glaucoma suspects showed a biphasic response in intraocular pressure (IOP). The hypertensive phase peaked 3 hrs after administration (at noon) and reached a maximum of 3.5 mm Hg (p less than 0.005) above the hypotensive phase. It is reported in the literature that during office hours untreated glaucoma patients show a peak near noon, suggesting that the initial increase in IOP may be the normal IOP pattern. When the data of untreated patients with POAG and glaucoma suspects were separated, an increase in IOP around noon in the first group and a decrease around noon in the glaucoma suspects was found. However, during GA-treatment both groups showed a hypertensive response at noon (3 hrs). In addition, the highest IOP's in day curves were timed during and without GA. It was shown that during GA there was a shift in the incidence of the highest IOP's towards noon (from 8.3% to 73.2% for patients with suspected glaucoma and from 32% to 63.6% for those with POAG). It was therefore concluded that GA induces a characteristic biphasic IOP pattern in patients with POAG as well as in glaucoma suspects. Also, glaucoma suspects may have higher peak pressures more frequently than POAG patients. Furthermore, the study showed that during office hours untreated glaucoma suspects have day curves with higher pressures in the morning while patients with POAG have higher pressures near noon.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7249915     DOI: 10.1007/bf00140885

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  8 in total

1.  The significance of the diurnal tension variations in normal and glaucomatous eyes.

Authors:  S M DRANCE
Journal:  Arch Ophthalmol       Date:  1960-10

2.  The pupillary, the intraocular pressure and the vasomotor responses to noradrenaline in rabbits.

Authors:  M E Langham; K Palewicz
Journal:  J Physiol       Date:  1977-05       Impact factor: 5.182

3.  The effect of topically applied guanethidine sulphate on pupil and tension responses of the rabbit eye to (--)-adrenaline bitartrate.

Authors:  J W Lamble
Journal:  Exp Eye Res       Date:  1974-07       Impact factor: 3.467

4.  Control of glaucoma by reduced dosage guanethidine-adrenaline formulation.

Authors:  D E Jones; D A Norton; D J Davies
Journal:  Br J Ophthalmol       Date:  1979-12       Impact factor: 4.638

5.  The biphasic intraocular pressure response of rabbits to epinephrine.

Authors:  M E Langham; G K Krieglstein
Journal:  Invest Ophthalmol       Date:  1976-02

6.  The combination of guanethidine 3% and adrenaline 0.5% in 1 eyedrop (GA) in glaucoma treatment.

Authors:  F J Hoyng; C L Dake
Journal:  Br J Ophthalmol       Date:  1979-01       Impact factor: 4.638

7.  Effects of prostaglandins and norepinephrine on ocular pressure and pupil size in rabbits following bilateral cervical ganglionectomy.

Authors:  M B Waitzman; W D Woods; W V Cheek
Journal:  Invest Ophthalmol Vis Sci       Date:  1979-01       Impact factor: 4.799

8.  [Clinical trials of various glaucoma drugs acting on the adrenergic system (author's transl)].

Authors:  U Urner-Bloch; J Bucheli; H Eltz; B Gloor; J Aeschlimann
Journal:  Klin Monbl Augenheilkd       Date:  1980-04       Impact factor: 0.700

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.